World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
21354
World Ranking
1010
National Ranking
461

David C. Kaslow publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David C. Kaslow sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 238 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David C. Kaslow D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David C. Kaslow sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David C. Kaslow is affiliated with the United States Food and Drug Administration in the United States. Their research primarily spans the field of Medicine, with a focus on topics relating to infectious diseases and public health. Kaslow's work addresses multiple subfields including Infectious Diseases, Health, Public Health, Environmental and Occupational Health, Epidemiology, and Endocrinology.

The scientist's recent publications include a range of papers that highlight ongoing research in vaccine response, public health security, and infectious diseases. Notable papers include:

  • Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review (2022, The Lancet Global Health)
  • Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic (2021, EClinicalMedicine)
  • Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review. (2022, PubMed)
  • The silent and dangerous inequity around access to COVID-19 testing: A call to action (2021, EClinicalMedicine)
  • KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine (2022, npj Vaccines)

Kaslow collaborates frequently with several researchers, contributing to a network of academic partnerships. Frequent co-authors include:

  • Annelies Wilder-Smith
  • Gagandeep Kang
  • Peter J. Hotez
  • Carolina Batista
  • Önder Ergönül

The scientist has published regularly in several academic journals, with the most frequent venues being:

  • npj Vaccines
  • Open Forum Infectious Diseases
  • Vaccine
  • EClinicalMedicine
  • The Lancet Global Health

Kaslow's research covers key topics such as:

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Streptococcal Infections and Treatments
  • Antimicrobial Resistance in Staphylococcus
  • Viral Infections and Outbreaks Research
  • Vibrio bacteria research studies

Best Publications

  • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  • A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

    Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes

  • A family of erythrocyte binding proteins of malaria parasites.

    J H Adams;B K Sim;S A Dolan;X Fang

  • Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

    Ally Olotu;Gregory Fegan;Juliana Wambua;George Nyangweso

  • A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.

    David C. Kaslow;Isabella A. Quakyi;Chiang Syin;Michael G. Raum

  • Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-l

    Andréa F. Egan;Joanne Morris;Guy Barnish;Stephen Allen

  • Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease.

    Mohammed Shahabuddin;Tetsuhiko Toyoshima;Masamichi Aikawa;David C. Kaslow

  • Sporadic Urban Leptospirosis

    Joseph M. Vinetz;Gregory E. Glass;Charles E. Flexner;Paul Mueller

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria.

    Rhian E. Hayward;Joseph L. DeRisi;Suad Alfadhli;David C. Kaslow

  • A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

    Oralee H. Branch;Venkatachalam Udhayakumar;Allen W. Hightower;Aggrey J. Oloo

  • Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals

    Unknown

  • Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes.

    R. W. Gwadz;D. Kaslow;Jong-Youn Lee;W. L. Maloy

  • Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.

    C Hirunpetcharat;J H Tian;D C Kaslow;N van Rooijen

  • Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

    Sanjai Kumar;Anjali Yadava;David B. Keister;Jing Hui Tian

  • malERA: An updated research agenda for malaria elimination and eradication.

    Regina N. Rabinovich;Regina N. Rabinovich;Chris Drakeley;Abdoulaye A. Djimde;B. Fenton Hall

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

    Jason A. Regules;Susan B. Cicatelli;Jason W. Bennett;Kristopher M. Paolino

  • A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.

    Patrick E Duffy;D C Kaslow

  • PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINE*

    Michael F. Good;David C. Kaslow;Louis H. Miller

  • Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

    Hajime Hisaeda;Hajime Hisaeda;Anthony W. Stowers;Takafumi Tsuboi;William E. Collins

Frequent Co-Authors

Louis H. Miller
Louis H. Miller National Institute of Allergy and Infectious Diseases
Michael F. Good
Michael F. Good Griffith University
Philip J. Barr
Philip J. Barr BayMedica, Inc.
William E. Collins
William E. Collins Centers for Disease Control and Prevention
Altaf A. Lal
Altaf A. Lal Sun Pharma (India)
Anthony A. Holder
Anthony A. Holder The Francis Crick Institute
Takafumi Tsuboi
Takafumi Tsuboi Ehime University
Chris Drakeley
Chris Drakeley London School of Hygiene & Tropical Medicine
Kent E. Kester
Kent E. Kester Walter Reed Army Institute of Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, branching into related online degrees can open up diverse career opportunities. One promising field is health information management, which combines healthcare knowledge with data management skills. Understanding the health information management bachelor degree salary can help guide decisions about pursuing this pathway.

Many respected programs offer flexibility for working professionals, such as online health information management degree programs cahiim accredited. These accreditations ensure that the curriculum meets industry standards, which is crucial for career advancement.

For those seeking quicker entry into the healthcare administration field, an accredited fast medical billing and coding certificate online provides practical skills in medical billing, coding, and documentation. This certification complements microbiology knowledge by supporting healthcare operations efficiently.

Additionally, students may explore various medical programs online that expand clinical and laboratory expertise. These programs offer the flexibility needed to balance studies with personal commitments while advancing specialized healthcare careers.

Best Scientists Citing David C. Kaslow

Trending Scientists